Conference abstract · 26 Sep 2016
Conference abstractPublished 14 Nov 2016
Protecting your animal healthcare products: Patent eligibility challenges in the USA and Europe
Sterne, Kessler, Goldstein & Fox P.L.L.C., USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
With the global animal healthcare market expected to exceed USD 40,000 million by 2020, the need to protect the underlying products will never be greater. Patents, among other forms of intellectual property, play a key role protecting products in this industry. However, recent decisions by USA courts have cast a cloud over several tools used for animal healthcare. For example, the USA Supreme Court's Myriad decision and subsequent rulings by the lower courts upended well-settled expectations in the USA regarding the patent eligibility of nature-based products, including polypeptides, polynucleotides, microorganisms and the products that they create. The USA is not alone in experiencing a significant disruption of patent law, as Europe went through a similar upheaval about 10 years ago. And while the law on patent eligibility at the European Patent Office (EPO) is now largely settled, the situation in the United States Patent and Trademark Office (USPTO) is less certain at present. An understanding of the similarities and differences between the EPO and USPTO is critical to a comprehensive patent portfolio strategy needed to succeed in the global animal healthcare market. This presentation will provide a summary of the EPO’s and USPTO’s approaches to examining patents in animal healthcare, including application of the USPTO’s examining guidelines to the tools used in and products made by the industry.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 23 Oct 2019
The Critical importance of new generation government engagement navigating government healthcare reforms and their impact in USA, Europe, Turkey & emerging markets
Conference abstract · 14 Jun 2019
The critical importance of new generation government engagement navigating government healthcare reforms and their impact in the USA, Europe, Turkey, and emerging markets
Conference abstract · 8 Jun 2018
Navigating government healthcare reforms and their impact in USA, Europe, Turkey & emerging markets
Conference abstract · 26 Oct 2015
Supplementary Protection Certificates (SPCs) in Europe – what is the ‘basic patent’ and what is the ‘product’?
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectNursing & Healthcare
- SubjectVeterinary & Animal Science
- BylineArticles whose byline prints “Jeremiah Frueauf”
